Get started
Author

Hiroyuki Uetake

Observed names: H Uetake, H. Uetake, HIROYUKI UETAKE, Hiroyuki UETAKE, Uetake, Hiroyuki
Observed institutions: University of Southern California, Tokyo Medical and Dental University, Kyushu University, Oita University, Sasaki Institute, National Kyushu Medical Center, Shizuoka Cancer Center, USC Norris Comprehensive Cancer Center, Saitama Cancer Center, The Cancer Institute Hospital, National Hospital Organization, National Cancer Center Hospital East, Osaka International Cancer Institute, National Disaster Medical Center, Institute of Science Tokyo Hospital, Japanese Foundation For Cancer Research, Institute of Science Tokyo, Chugai Pharmaceutical Co., Ltd. (Japan), The University of Tokyo, Teikyo University, Yokohama City University
ORCID: 0000-0001-7162-6842
Observed ORCID: 0000-0001-7162-6842
OpenAlex ID: A5024247368
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
2019 · Yojiro Hashiguchi, Kei Muro, et al. · International Journal of Clinical Oncology · 1,922
PDF
ERCC1 and Thymidylate Synthase mRNA Levels Predict Survival for Colorectal Cancer Patients Receiving Combination Oxaliplatin and Fluorouracil Chemotherapy
2001 · Yoshinori Shirota, Jan Stoehlmacher, et al. · Journal of Clinical Oncology · 610
Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer
2023 · Jun Watanabe, Kei Muro, et al. · JAMA · 273
PDF
Cyclooxygenase-2 Expression
2004 · Labile Togba Soumaoro, Hiroyuki Uetake, et al. · Clinical Cancer Research · 250
Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression.
2001 · K Kawakami, D Salonga, et al. · PubMed · 227
Clinical Significance of High Mobility Group A2 in Human Gastric Cancer and Its Relationship to let-7 MicroRNA Family
2008 · Kazuo Motoyama, Hiroshi Inoue, et al. · Clinical Cancer Research · 219
Clinical Significance of Osteoprotegerin Expression in Human Colorectal Cancer
2011 · Shunsuke Tsukamoto, Toshiaki Ishikawa, et al. · Clinical Cancer Research · 210
Lactate Dehydrogenase-5 (LDH-5) Expression in Human Gastric Cancer: Association with Hypoxia-Inducible Factor (HIF-1α) Pathway, Angiogenic Factors Production and Poor Prognosis
2008 · Yanislav Kolev, Hiroyuki Uetake, et al. · Annals of Surgical Oncology · 191
CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21 ‘gene desert’, serve as important prognostic biomarkers in colorectal cancer
2017 · T. Ozawa, T. Matsuyama, et al. · Annals of Oncology · 170
Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.
2003 · Wataru Ichikawa, Hiroyuki Uetake, et al. · PubMed · 153
Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial
2019 · Hideki Ueno, Megumi Ishiguro, et al. · Journal of Clinical Oncology · 149
PIK3CAmutation is predictive of poor survival in patients with colorectal cancer
2007 · Shunsuke Kato, Satoru Iida, et al. · International Journal of Cancer · 141
PDF
The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling
2020 · Baoqing Chen, Mihnea P. Dragomir, et al. · Gastroenterology · 131
Screening for epigenetically masked genes in colorectal cancer Using 5-Aza-2'-deoxycytidine, microarray and gene expression profile.
2012 · Ahmed Khamas, Toshiaki Ishikawa, et al. · PubMed · 127
Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer
2003 · W Ichikawa, H Uetake, et al. · British Journal of Cancer · 127
PDF
Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas.
1998 · T Fujita, M Matsui, et al. · PubMed · 123
Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer
2024 · Kohei Shitara, Kei Muro, et al. · Nature Medicine · 121
PDF
MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer
2010 · Takatoshi Matsuyama, Toshiaki Ishikawa, et al. · International Journal of Cancer · 116
PDF
Morphologic change of the psoas muscle as a surrogate marker of sarcopenia and predictor of complications after colorectal cancer surgery
2017 · Marie Hanaoka, Masamichi Yasuno, et al. · International Journal of Colorectal Disease · 105
Prognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a Phase 3 study (SACURA Trial)
2021 · Hideki Ueno, Megumi Ishiguro, et al. · British Journal of Cancer · 92
PDF
Clinical Significance of BMP7 in Human Colorectal Cancer
2008 · Kazuo Motoyama, Fumiaki Tanaka, et al. · Annals of Surgical Oncology · 92
The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer
2020 · Kunitoshi Shigeyasu, Shusuke Toden, et al. · Molecular Cancer · 88
PDF
miR-544ainduces epithelial–mesenchymal transition through the activation of WNT signaling pathway in gastric cancer
2015 · Yoshimitsu Yanaka, Tomoki Muramatsu, et al. · Carcinogenesis · 81
PDF
Prognostic Significance of VEGF Expression in Correlation With COX-2, Microvessel Density, and Clinicopathological Characteristics in Human Gastric Carcinoma
2007 · Yanislav Kolev, Hiroyuki Uetake, et al. · Annals of Surgical Oncology · 80
12-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II/III Colon Cancer With Surgery Alone: The SUNRISE Study
2016 · Takeharu Yamanaka, Eiji Oki, et al. · Journal of Clinical Oncology · 76
Works count: 442
Citation count: 9,047
H-index: 43
I10-index: 117
Year
Topic
Type